Spots Global Cancer Trial Database for avastin (bevacizumab)
Every month we try and update this database with for avastin (bevacizumab) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer | NCT02810457 | Carcinoma, Non-... | FKB238 (bevaciz... Avastin (bevaci... Paclitaxel Carboplatin | 18 Years - | Centus Biotherapeutics Limited | |
| Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer | NCT02810457 | Carcinoma, Non-... | FKB238 (bevaciz... Avastin (bevaci... Paclitaxel Carboplatin | 18 Years - | Centus Biotherapeutics Limited | |
| A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer | NCT00109070 | Colorectal Canc... | Avastin (bevaci... | 18 Years - | Genentech, Inc. | |
| Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor | NCT00458315 | Unknown Primary... | Cisplatin Paclitaxel Gemcitabine Avastin (Bevaci... | 18 Years - 70 Years | Rigshospitalet, Denmark | |
| Preop Chemoradiation Resectable Pancreas | NCT00336648 | Pancreatic Neop... | Avastin (Bevaci... Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | NCT00096967 | Breast Cancer Colorectal Canc... Metastases | Avastin (bevaci... | - | Genentech, Inc. | |
| Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer | NCT00557492 | Pancreatic Canc... | Avastin (bevaci... Gemzar (Gemcita... external beam r... | 18 Years - 80 Years | University of Pittsburgh | |
| An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | NCT00109057 | Cancer | Avastin (bevaci... | - | Genentech, Inc. | |
| A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) | NCT00095225 | Non-Small-Cell ... Neoplasm Recurr... | Avastin (bevaci... Tarceva (erloti... | 18 Years - | Genentech, Inc. | |
| A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer | NCT00109226 | Colorectal Canc... | Avastin (Bevaci... | 18 Years - | Genentech, Inc. | |
| Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer | NCT00681876 | Colorectal Canc... | Irinotecan Avastin Erbitux | 18 Years - 72 Years | Hellenic Oncology Research Group | |
| Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer | NCT00557492 | Pancreatic Canc... | Avastin (bevaci... Gemzar (Gemcita... external beam r... | 18 Years - 80 Years | University of Pittsburgh | |
| A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer | NCT00109070 | Colorectal Canc... | Avastin (bevaci... | 18 Years - | Genentech, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
